Regulation of Plant-Based Pharmaceuticals.
Examines the regulation of plant-based pharmaceuticals, including the potential benefits and risks of plant-based proteins, the role of the Animal and Plant Health Inspection Service and FDA in biotechnology regulation, and regulatory issues and concerns.
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2003.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Examines the regulation of plant-based pharmaceuticals, including the potential benefits and risks of plant-based proteins, the role of the Animal and Plant Health Inspection Service and FDA in biotechnology regulation, and regulatory issues and concerns. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |